|
|
 |
|
Viewing report
|
|
|
|
InNexus Biotechnology Inc. - Product Pipeline Review - H2 2011
Global Markets Direct, Nov 2011, Pages: 68
InNexus Biotechnology Inc. – Product Pipeline Review – H2 2011
Summary
Global Market Direct’s pharmaceuticals report, “InNexus Biotechnology Inc. - Product Pipeline Review - H2 2011” provides data on the InNexus Biotechnology Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, InNexus Biotechnology Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from InNexus Biotechnology Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- InNexus Biotechnology Inc. - Brief InNexus Biotechnology Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of InNexus Biotechnology Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of InNexus Biotechnology Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the InNexus Biotechnology Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate InNexus Biotechnology Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of InNexus Biotechnology Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the InNexus Biotechnology Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with InNexus Biotechnology Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of InNexus Biotechnology Inc. and identify potential opportunities in those areas.
Keywords
Current R&D Portfolio of InNexus Biotechnology Inc.; InNexus Biotechnology Inc. - Key Therapeutics; InNexus Biotechnology Inc. - Pipeline Overview and Promising Molecules; InNexus Biotechnology Inc. - News; InNexus Biotechnology Inc. - Latest Updates; InNexus Biotechnology Inc. - Pipeline; InNexus Biotechnology Inc. - Discontinued/Dormant Projects
|
|
|
|
